Particle News: Latest BioNTech SE news

Moderna Wins Patent Case Against BioNTech and Pfizer Over mRNA Technology

A German court has ruled in favor of Moderna, ordering BioNTech and Pfizer to disclose profits and pay damages for patent infringement.

BioNTech Moves to Complete $1.25 Billion Curevac Takeover

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

GSK Secures $370 Million After CureVac US Patent Settlement

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

Germany Awards National Prize to Biontech Founders Sahin and Türeci

Same-Arm Boosters Found to Enhance Early Vaccine Response

HHS Secretary RFK Jr. Weighs Removing COVID-19 Vaccine From Childhood Schedule

BioNTech to Acquire CureVac for $1.25 Billion

UK Finalizes £1bn BioNTech Deal to Advance mRNA Cancer Vaccines and AI Research

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy